Clinical Trial

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

Name: A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations — clinical trial record (NCT07345689)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The objective of this study is to evaluate the pharmacokinetic profile and safety of anaprazole sodium in adult subjects, particularly including the elderly and those with renal or hepatic impairment.

Trial Details

NCT Number	NCT07345689
Lead Sponsor	Xuanzhu Biopharmaceutical Co., Ltd.
Conditions	Hepatic Insufficiency, Renal Insufficiency, Elderly
Enrollment	60 participants
Start Date	2026-01-30
Primary Completion	2026-10-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-16